New hope for Hard-to-Treat colorectal cancer: drug cocktail trial launches

NCT ID NCT04068610

Ongoing Disease control Sponsor: MedImmune LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This study tests whether adding new cancer drugs to standard chemotherapy and bevacizumab can better control metastatic microsatellite-stable colorectal cancer. About 61 adults with this advanced cancer will receive different treatment combinations. The goal is to find safer, more effective first-line therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colonic neoplasm colorectal cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER

Contacts and locations

Locations

Research Site

Los Angeles, California, 90095, United States
Research Site

Sacramento, California, 95817, United States
Research Site

Ann Arbor, Michigan, 48109, United States
Research Site

Las Vegas, Nevada, 89169, United States
Research Site

New York, New York, 10065, United States
Research Site

Canton, Ohio, 44718, United States
Research Site

Providence, Rhode Island, 02903, United States
Research Site

Chattanooga, Tennessee, 37404, United States
Research Site

Nashville, Tennessee, 37203, United States
Research Site

Houston, Texas, 77030, United States
Research Site

Charlottesville, Virginia, 22908, United States
Research Site

Clayton, 3168, Australia
Research Site

Heidelberg, 3084, Australia
Research Site

Melbourne, 3000, Australia
Research Site

Toronto, Ontario, M5G 1X6, Canada
Research Site

Nantes, 44000, France
Research Site

Villejuif, 94805, France
Research Site

Barcelona, 08035, Spain
Research Site

Barcelona, 08916, Spain
Research Site

Madrid, 28027, Spain
Research Site

Madrid, 28046, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.